TOWA PHARMACEUTICAL CO.,LTD. (4553)

Market cap
¥220.2B
P/E ratio
11.9x
Towa Pharmaceutical manufactures and sells generic drugs to hospitals and distributors in Japan, Europe, and North America through its own facilities and subsidiaries.
Period EndIncome before tax (Million JPY)YoY (%)
Mar 31, 202526,152+6.84%
Mar 31, 202424,477+376.11%
Mar 31, 20235,141-77.39%
Mar 31, 202222,739+21.75%
Mar 31, 202118,677-11.02%
Mar 31, 202020,990+11.26%
Mar 31, 201918,865+61.01%
Mar 31, 201811,717+57.97%
Mar 31, 20177,417-26.98%
Mar 31, 201610,157-34.20%
Mar 31, 201515,437+74.75%
Mar 31, 20148,834-7.44%
Mar 31, 20139,544-3.02%
Mar 31, 20129,841
AI Chat